entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,31.8162292282809,-0.445248759438613,0.361383961634795,-1.23206563297507,0.217924567912277,0.696627732654312,NA
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,22.9710277377555,-0.171521171846809,0.396810554536376,-0.432249520296178,0.665560071484286,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,67.5576209941878,-0.0722299866331454,0.289726490116905,-0.249304047427629,0.803125600755175,0.933906632050025,A549
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,60.3705099460037,-0.185621165841364,0.259494964280255,-0.715317024961199,0.474413170902762,0.986418245486816,A549
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,22.1779207347039,0.173082773561067,0.652713782119039,0.265174075226592,0.790875365190193,0.927008810119352,A549
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,9.09224308081409,0.169065287687495,0.551801103722848,0.306388092642184,0.759309173409089,1,sigmoid colon organoid
388165,UBE2Q2P1,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,9.09224308081409,-0.759958380364545,0.598030467916756,-1.27076866670668,0.203810958795383,0.917635520894922,sigmoid colon organoid
